Results for tag: "Samarium-153"

Samarium-153 is a radiopharmaceutical used in nuclear medicine for the treatment of bone pain due to metastatic bone cancer. It is a man-made radioactive isotope of the element samarium, and is produced in a nuclear reactor. Samarium-153 is administered intravenously and binds to the hydroxyapatite crystals in the bone, where it emits beta particles that destroy the cancer cells. It is also used in imaging studies to detect bone metastases. The Samarium-153 market is composed of companies that produce and distribute the radiopharmaceutical. These companies are typically involved in the production of the isotope, its formulation into a therapeutic dose, and its distribution to hospitals and clinics. Companies in the Samarium-153 market include Eckert & Ziegler, Jubilant Radiopharma, and IBA Molecular. Show Less Read more